Showing results 1 to 1 of 1
Issue Date | Title | Author(s) |
---|---|---|
2012-04 | Using combination therapy to override stromal-mediated chemoresistance in mutant FLT3-positive AML: synergism between FLT3 inhibitors, dasatinib/multi-targeted inhibitors and JAK inhibitors | E Weisberg; Q Liu; Erik Nelson; A L Kung; A L Christie; R Bronson; M Sattler; T Sanda; Z Zhao; 허우영; C Mitsiades; R Smith; JF Daley; R Stone; I Galinsky; JD Griffin; N Gray |